P Bouhours
Overview
Explore the profile of P Bouhours including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amado I, Bourdel M, Daban C, Poirier M, Loo H, Bouhours P, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2009 Jun;
33(7):1107-12.
PMID: 19527763
Introduction: Visual orientation and attention are impaired in schizophrenia. Engagement and disengagement of attention and the ability to prompt responses to a stimulus in patients before and after six weeks...
2.
Llorca P, Bouhours P, Moreau-Mallet V
Encephale
. 2008 Jul;
34(2):170-8.
PMID: 18597725
Objective: To investigate the efficacy and tolerability of direct initiation of long-acting injectable risperidone (LAIR) in adults with schizophrenia or other psychotic disorders requiring a change of treatment. Methods: Patients...
3.
Mannaert E, Vermeulen A, Remmerie B, Bouhours P, Levron J
Encephale
. 2006 Apr;
31(5 Pt 1):609-15.
PMID: 16598965
The single dose pharmacokinetic profiles of long-acting injectable (LAI) risperidone and oral risperidone were extrapolated to steady-state. Plasma concentrations of the active moiety (unchanged risperidone + 9-hydroxy-risperidone) were measured by...
4.
Kissling W, Heres S, Lloyd K, Sacchetti E, Bouhours P, Medori R, et al.
J Psychopharmacol
. 2005 Sep;
19(5 Suppl):15-21.
PMID: 16144782
This report presents data from the extension phase of a 6-month trial that evaluated the efficacy of risperidone long-acting injectable (RLAI) in stable psychotic patients requiring a treatment change. Patients...
5.
Allain H, Tessier C, Bentue-Ferrer D, Tarral A, Le Breton S, GANDON M, et al.
Psychopharmacology (Berl)
. 2002 Dec;
165(4):419-29.
PMID: 12459926
Rationale: Dementia includes not only cognitive deficit but may also include psychiatric and behavioral symptoms. These psychological symptoms of dementia require specific treatment without deleterious effects on cognitive functions. Objective:...
6.
Pageaux G, Micallef J, Nataf M, Levron J, Lacarelle B, Le Moing J, et al.
Br J Clin Pharmacol
. 2001 Mar;
51(2):164-8.
PMID: 11259989
Aims: The primary objective of this study was to determine how the pharmacokinetics of sabeluzole, an investigational drug with specific effects on memory and learning abilities, are affected by chronic...
7.
Blin O, Azorin J, Bouhours P
J Clin Psychopharmacol
. 1996 Feb;
16(1):38-44.
PMID: 8834417
The subjects were 62 patients hospitalized for acute exacerbations of schizophrenia and were randomly assigned to receive risperidone (mean dose, 7.4 mg/day), haloperidol (7.6 mg/day), or methotrimeprazine (100 mg/day) for...
8.
Leroux J, Elia E, Jacquet M, Pommery J, Levron J, Bouhours P, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 1994 Mar;
18(2):347-53.
PMID: 8208983
1. The authors attempted to correlate plasma concentrations in H/rH and clinical efficacy from 8 schizophrenic patients (DSM IIIR) on H. 2. No significant correlations were found between H, rH...
9.
Danjou P, Warot D, Hergueta T, Lacomblez L, Bouhours P, Puech A
Int Clin Psychopharmacol
. 1992 Nov;
7(2):73-9.
PMID: 1487624
The new potential anxiolytic ritanserin was studied in a double-blind manner vs. alprazolam, diazepam and placebo in 23 healthy subjects. The subjects belonged either to a high anxiety level group...
10.
Remond A, Bouhours P
Neurophysiol Clin
. 1988 Apr;
18(2):153-60.
PMID: 3386620
A study of event-related brain potentials (ERPs) in Alzheimer type dementia has been performed on 6 elderly subjects (mean age: 67.5). Patients were included if they met DSM-III criteria for...